Please Join Our

Agendia Sponsored ASBrS Webinar


Genomic Profiling of Early Stage Breast Cancer: Expanding Applications to Improve Outcomes

Join Us December 14th, 7:00 pm – 8:00 pm ET, Webinar


  • Cathy L. Graham, MD, FACS
  • William Audeh, MD, MS

This webinar will empower you with data demonstrating the utility of Agendia’s assays, MammaPrint® and BluePrint®, for patients with breast cancer. Review the latest data and learn about the real-world impact of MammaPrint and BluePrint. Please join us for an informative, interactive webinar.

How to view the recorded presentation:

Click Here To View Recording

About The Speakers

Cathy L. Graham, MD, FACS

Cathy L. Graham, MD, FACS is an Assistant Professor of Surgery in the Division of Surgical Oncology of the Department of Surgery at Emory University School of Medicine and is the Director of Breast Surgery at Emory Saint Joseph’s Hospital in Atlanta, Georgia. A board-certified breast surgeon, Dr. Graham’s clinical interests include benign and malignant breast disease, breast cancer risk assessment, risk modification and personalized breast cancer treatment. She has over 25 years of experience in breast surgery. She holds special certification in breast ultrasound, ultrasound guided biopsy and stereotactic biopsy. She is actively involved in clinical research through her affiliation with Winship Cancer Institute and is a Principal Investigator for the FLEX Trial.

William Audeh, MD, MS

William Audeh, MD, MS, Chief Medical Officer at Agendia, is a medical oncologist specializing in breast cancer, with nearly 30 years of experience as a clinician and clinical researcher at the Cedars-Sinai Cancer Center in Los Angeles. Prior to joining Agendia, and in addition to his clinical practice, he served as the former Director of the Cedars-Sinai Cancer Center and Medical Director of the Wasserman Breast Cancer Risk Reduction Program. Dr. Audeh has been Principal Investigator on a wide variety of national and international clinical and translational trials, and has authored numerous publications in the field of breast cancer, cancer genomics and targeted cancer therapy.

Previous Recorded Webinars


The Clinical Utility of BluePrint and MammaPrint in the Pre- and Post-Operative Treatment Settings

Join Us Monday, October 19th, 7:00 pm – 8:00 pm ET, Webinar

Alberto Montero, MD; Director Breast Cancer Program, UH Seidman Cancer Center; Associate Professor, CWRU School of Medicine

James Pellicane, MD; Director of Breast Oncology, Bon Secours Cancer Institute

Please join our webinar for an interactive discussion of comprehensive genomic profiling and how it can facilitate patient-centered care. Dr. Montero will provide updates on the NBRST and MINDACT clinical trials and discuss the utility of MammaPrint and BluePrint in the pre- and post-operative treatment settings with Dr. Pellicane. We look forward to an impactful webinar and welcome audience participation during the Q&A session.

View The Recorded Webinar

Dr. Montero

Alberto Montero, MD, MBA, CPHQ, is clinical director of the Breast Cancer Medical Oncology Program at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University School of Medicine. He is board certified in medical oncology by the American Board of Internal Medicine.Dr. Montero has been in academic practice for over 13 years and has demonstrated a strong track record of clinical research in breast cancer. Prior to joining the UH Seidman Cancer Center team, Dr. Montero spent seven years at the Cleveland Clinic, where he served as a staff physician in the hematology and oncology department, as well as chief quality improvement officer and patient experience officer. Before that, Dr. Montero was on staff at University of Miami Sylvester Cancer Center as Breast Cancer Site Disease Group co-leader, and at the Medical University of South Carolina Division of Hematology/Oncology.

Dr. Pellicane

Dr. James Pellicane received his undergraduate degree from The Johns Hopkins University and his medical degree from the University of Pittsburgh School of Medicine. He completed his General Surgery residency at Virginia Commonwealth University The Medical College of Virginia and is board certified by the American Board of Surgery.

He is a fellow of the American College of Surgeons and is an active member of The American Society of Breast Surgeons. He co-founded Virginia Breast Center in 2005 and affiliated with Bon Secours in 2008 now with 3 surgeons serving all 4 Bon Secours hospitals in Richmond. Dr. Pellicane currently is the Director of Breast Oncology at the Bon Secours Cancer Institute in Richmond, VA.


Trusted by leading physicians and institutions around the world

Genomic Testing Cell Photo

Completed Studies

Data on the validation and utility of MammaPrint and BluePrint for patients with early stage breast cancer.

See the mindact trial
Two women reading about genomic breast cancer results

Latest News

Agendia Presents New Data Demonstrating MammaPrint’s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients […]

Read the article
I Am Here breast cancer illustration

Patient News

Agendia and artist Andrea Caceres go “beyond the mammogram” in a portrait series illustrating people touched by breast cancer.

View the documentary
  • This field is for validation purposes and should be left unchanged.

For the US, Puerto Rico, and South America

Agendia Inc. USA
22 Morgan
Irvine, CA 92618
(888) 321-2732

For outside the Americas

Agendia NV
Radarweg 60
1043 NT Amsterdam
The Netherlands
+31 (0)20 462 1510